Epivir-HBV-–-Advanced-Antiviral-Therapy-for-Chroni
Epivir HBV
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | 1.77 $ | 53.00 $ (0%) | 🛒 Add to cart |
| 60 | 1.28 $ | 106.00 $ 77.00 $ (27%) | 🛒 Add to cart |
| 90 | 1.11 $ | 159.00 $ 100.00 $ (37%) | 🛒 Add to cart |
| 120 | 1.03 $ | 212.00 $ 124.00 $ (42%) | 🛒 Add to cart |
| 180 | 0.95 $ | 318.00 $ 171.00 $ (46%) | 🛒 Add to cart |
| 270 | 0.89 $ | 477.00 $ 241.00 $ (49%) | 🛒 Add to cart |
| 360 | 0.86 $
Best per pill | 636.00 $ 310.00 $ (51%) | 🛒 Add to cart |
Synonyms | |||
Epivir HBV (lamivudine) is a potent nucleoside analogue reverse transcriptase inhibitor (NRTI) specifically formulated for the treatment of chronic hepatitis B virus (HBV) infection. Clinically proven to suppress viral replication, Epivir HBV reduces liver inflammation and fibrosis, improving long-term patient outcomes. With high bioavailability and a well-tolerated safety profile, it is a trusted choice for healthcare providers worldwide.
Key Technical Specifications
- Active Ingredient: Lamivudine (100 mg)
- Dosage Form: Film-coated tablets
- Pharmacokinetics:
- Bioavailability: ~86%
- Half-life: 5–7 hours
- Metabolism: Minimal hepatic metabolism, primarily renal excretion
- Storage Conditions: Store below 30°C (86°F), protect from moisture
- Manufacturer: GlaxoSmithKline (GSK)
- Regulatory Approvals: FDA, EMA, WHO prequalified
Why Choose Epivir HBV?
1. Clinically Proven Efficacy
- Viral Load Reduction: Up to 4-log reduction in HBV DNA levels within 12 weeks.
- ALT Normalization: Restores liver enzyme levels in >50% of patients.
- HBeAg Seroconversion: Promotes immune clearance in ~20% of cases after 1 year.
2. Superior Safety Profile
- Low Resistance Risk: Compared to older NRTIs.
- Minimal Side Effects: Well-tolerated, with most adverse effects being mild (headache, fatigue).
3. Cost-Effective Treatment
- Affordable: Priced competitively vs. newer HBV antivirals.
- Generic Availability: Reduces healthcare costs without compromising efficacy.
4. Convenient Dosage
- Once-Daily Regimen: Enhances patient compliance.
Epivir HBV Rating: ★★★★☆ (4.2/5)
| Aspect | Rating |
|---|---|
| Efficacy | ★★★★☆ |
| Safety | ★★★★☆ |
| Affordability | ★★★★★ |
| Convenience | ★★★★☆ |
Pricing Comparison (30-Tablet Pack)
| Region | Price (USD) |
|---|---|
| USA | $120–$150 |
| Europe | €90–€110 |
| India (Generic) | $25–$40 |
| Canada | $80–$100 |
(Prices may vary based on pharmacy and insurance coverage.)
Customer Testimonials
Dr. Alan K., Hepatologist (USA):
“Epivir HBV remains a first-line option for my HBV patients due to its reliability and cost-effectiveness. Resistance is manageable with proper monitoring.”
Patient Review (UK):
“After 6 months on Epivir HBV, my viral load dropped significantly. No side effects—highly recommend!”
Healthcare Provider (India):
“The generic version offers the same efficacy at a fraction of the cost. A game-changer in developing markets.”
Conclusion: A Trusted Solution for HBV Management
Epivir HBV combines proven efficacy, safety, and affordability, making it a cornerstone in chronic hepatitis B therapy. Whether as a standalone treatment or part of a combination regimen, it delivers consistent results with minimal complications.
Consult your healthcare provider today to see if Epivir HBV is right for you or your patients.
(Disclaimer: This product requires a prescription. Always follow medical advice.)
Key Takeaways for Buyers:
✅ Effective HBV suppression
✅ Low adverse event risk
✅ Budget-friendly options available
✅ Trusted by medical professionals
For bulk orders or institutional pricing, contact authorized distributors.